Jeffrey A. Zonder

Also affiliated with The Barbara Ann Karmanos Cancer Institute, Amyloidosis Foundation, Michigan United

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma”.

Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma

New England Journal of Medicine(2022)10.1056/nejmoa2204925

N/A

6.2DataRank · unranked

474 citations

Susanna Jacobus, Edie Weller, Hani Hassoun, Sagar Lonial, Noopur Raje +51 more

Bortezomib, lenalidomide, and dexamethasone with or without elotuzumab in patients with untreated, high-risk multiple myeloma (SWOG-1211): primary analysis of a randomised, phase 2 trial

The Lancet Haematology(2020)10.1016/s2352-3026(20)30354-9

N/A

3.8DataRank · unranked

126 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Sandi Hita +12 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

Blood Advances(2020)10.1182/bloodadvances.2019000491

N/A

1.1DataRank · unranked

31 citations

Niels Weinhold, Gregory Song, Kristin A. Rand, David Van Den Berg, Amie E. Hwang +65 more

Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4929

N/A

0.953DataRank · unranked

25 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Circular RNAs in acute myeloid leukemia

Molecular Cancer(2021)10.1186/s12943-021-01446-z

N/A

0DataRank · unranked

63 citations

Md. Hafiz Uddin, Jeffrey A. Zonder, Asfar S. Azmi, Suresh Kumar Balasubramanian, Vijendra K. Singh

PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma

Cancers(2021)10.3390/cancers14010160

N/A

0DataRank · unranked

19 citations

Md. Hafiz Uddin, Suresh Kumar Balasubramanian, Noor A. Sulaiman, Marium Iqbal, Mahmoud Chaker +8 more

Immune biomarkers of response to immunotherapy in patients with high-risk smoldering myeloma

Cancer Cell(2022)10.1016/j.ccell.2022.10.017

N/A

0DataRank · unranked

64 citations

Michelle P. Aranha, Robert Redd, Joanna Bagińska, Nicholas J. Haradhvala, Margaret Hallisey +34 more

Randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8054

N/A

0DataRank · unranked

4 citations

Antje Hoering, Sikander Ailawadhi, Rachael Sexton, Brea Lipe, Jason Valent +11 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Data from Selinexor in Combination with R-CHOP for Frontline Treatment of Non-Hodgkin Lymphoma: Results of a Phase I Study

(2023)10.1158/1078-0432.c.6530103.v1

N/A

0DataRank · unranked

0 citations

Husain Yar Khan, Yiwei Li, Mahmoud Chaker, Irfana Muqbil, Amro Aboukameel +18 more

Dose Escalation of ISB 1442, a Novel CD38 Biparatopic x CD47 Bispecific Antibody, in Patients with Relapsed / Refractory Multiple Myeloma

Blood(2024)10.1182/blood-2024-209952

N/A

0DataRank · unranked

1 citations

Hang Quach, Phoebe Joy Ho, Andrew Spencer, Mark A. Schroeder, Peter Tan +12 more

A meta-analysis of genome-wide association studies of multiple myeloma among men and women of African ancestry

UNC Libraries(2024)10.17615/ct6n-5k64

N/A

0DataRank · unranked

0 citations

David V. Conti, J Mehta, Thomas G. Martin, Kenneth C. Anderson, Song, G.C. +65 more

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide, and dexamethasone (VRd) for initial therapy of newly diagnosed multiple myeloma (NDMM): Results of ENDURANCE (E1A11) phase III trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.18_suppl.lba3

N/A

0DataRank · unranked

31 citations

Susanna Jacobus, Adam D. Cohen, Matthias Weiss, Natalie S. Callander, Avina A. Singh +15 more

Primary analysis of the randomized phase II trial of bortezomib, lenalidomide, dexamthasone with/without elotuzumab for newly diagnosed, high-risk multiple myeloma (SWOG-1211).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8507

N/A

0DataRank · unranked

26 citations

Sikander Ailawadhi, Rachael Sexton, Antje Hoering, Brea Lipe, Sandi Hita +9 more

A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci

UNC Libraries(2020)10.17615/hhzp-hr83

N/A

0DataRank · unranked

0 citations

Elad Ziv, Wendy Cozen, Andrew F. Olshan, Nathaniel Rothman, Thomas G. Martin +95 more